These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 32828748)

  • 1. Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
    Toyé RM; Lô G; Diop-Ndiaye H; Cissé AM; Ndiaye AJS; Kébé-Fall K; Dramé A; Cohen D; Pujol FH; Mboup S; Boye CS; Chemin I; Laborde-Balen G; Taverne B; Touré-Kane C
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101502. PubMed ID: 32828748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern India.
    Saha D; Pal A; Biswas A; Panigrahi R; Sarkar N; Sarkar J; Pal M; Guha SK; Saha B; Chakrabarti S; Chakravarty R
    PLoS One; 2013; 8(8):e73613. PubMed ID: 24023688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi.
    Aoudjane S; Chaponda M; González Del Castillo AA; O'Connor J; Noguera M; Beloukas A; Hopkins M; Khoo S; van Oosterhout JJ; Geretti AM
    Clin Infect Dis; 2014 Dec; 59(11):1618-26. PubMed ID: 25100867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia.
    Tamandjou Tchuem CR; Brandt L; Nel ER; Cotton MF; Matthews P; Kaindjee-Tjituka F; Preiser W; Andersson MI
    PLoS One; 2020; 15(9):e0238839. PubMed ID: 32915862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B screening practices and viral control among persons living with HIV in urban Senegal.
    Ramírez Mena A; Tine JM; Fortes L; Ndiaye O; Ka D; Ngom NF; Ramette A; Bittel P; Seydi M; Wandeler G;
    J Viral Hepat; 2022 Jan; 29(1):60-68. PubMed ID: 34610183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus clinical and virologic characteristics in an HIV perinatal transmission study in sub-Saharan Africa.
    Bhattacharya D; Guo R; Tseng CH; Emel L; Sun R; Zhang TH; Chiu SH; Stranix-Chibanda L; Chipato T; Ship H; Mohtashemi NZ; Kintu K; Manji KP; Moodley D; Maldonado Y; Currier JS; Thio CL
    AIDS; 2024 Mar; 38(3):329-337. PubMed ID: 37861675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of lamivudine-resistance-associated vaccine-escape HBV mutants among HIV-coinfected patients on prolonged antiretroviral therapy.
    Pal A; Sarkar N; Saha D; Guha SK; Saha B; Chakrabarti S; Chakravarty R
    Antivir Ther; 2015; 20(5):545-54. PubMed ID: 25654813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa.
    Makondo E; Bell TG; Kramvis A
    PLoS One; 2012; 7(9):e46345. PubMed ID: 23029487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon.
    Bivigou-Mboumba B; François-Souquière S; Deleplancque L; Sica J; Mouinga-Ondémé A; Amougou-Atsama M; Chaix ML; Njouom R; Rouet F
    PLoS One; 2016; 11(1):e0143869. PubMed ID: 26764909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy.
    Day SL; Odem-Davis K; Mandaliya KN; Jerome KR; Cook L; Masese LN; Scott J; Kim HN; Graham SM; McClelland RS
    PLoS One; 2013; 8(3):e59346. PubMed ID: 23527168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia.
    Deressa T; Damtie D; Fonseca K; Gao S; Abate E; Alemu S; Aleka Y; Swain MG; van Marle G; Coffin CS
    PLoS One; 2017; 12(12):e0190149. PubMed ID: 29281718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
    Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
    PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China.
    Huang SM; Cai WP; Hu FY; Lan Y; Liao BL; Chen YP; Tang XP
    Int J STD AIDS; 2016 Sep; 27(10):890-7. PubMed ID: 26384940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
    Archampong TN; Lartey M; Sagoe KW; Obo-Akwa A; Kenu E; Gillani FS; Yang H; Boamah I; Flanigan T; Kwara A
    BMC Infect Dis; 2016 Jan; 16():14. PubMed ID: 26759172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
    AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.
    Wandeler G; Musukuma K; Zürcher S; Vinikoor MJ; Llenas-García J; Aly MM; Mulenga L; Chi BH; Ehmer J; Hobbins MA; Bolton-Moore C; Hoffmann CJ; Egger M;
    PLoS One; 2016; 11(3):e0152043. PubMed ID: 27032097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand.
    Khamduang W; Gaudy-Graffin C; Ngo-Giang-Huong N; Jourdain G; Moreau A; Luekamlung N; Halue G; Buranawanitchakorn Y; Kunkongkapan S; Buranabanjasatean S; Lallemant M; Sirirungsi W; Goudeau A;
    PLoS One; 2012; 7(7):e42184. PubMed ID: 22860080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals.
    Cooley L; Ayres A; Bartholomeusz A; Lewin S; Crowe S; Mijch A; Locarnini S; Sasadeusz J
    AIDS; 2003 Jul; 17(11):1649-57. PubMed ID: 12853747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.